Response-guided therapy in patients with genotype 1 hepatitis C virus: Current status and future prospects

Medicine and Dentistry

• Therapeutic Procedure 100%
• Combination Therapy 66%
• Inpatient 50%
• Antiviral Therapy 33%
• Interferon 33%
• Antivirus Agent 33%
• Ribavirin 33%
• Viral Clearance 33%
• Peginterferon 33%
• Treatment Response 16%
• Side Effect 16%
• Treatment Duration 16%
• Genotype 16%
• Hepatitis C 16%
• Hepatitis C Virus 16%
• Virus Replication 16%
• Development 16%
• Virotherapy 16%
• Telaprevir 16%
• Boceprevir 16%
• Hepatitis C Virus Genotype 1 16%
• Comprehension 16%
• Assessment 16%
• Patient 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Interferon 33%
• Antivirus Agent 33%
• Ribavirin 33%
• Viral Clearance 33%
• Peginterferon 33%
• Clinical Trial 33%
• Side Effect 16%
• Tolerability 16%
• Hepatitis C Virus 16%
• Hepatitis C 16%
• Telaprevir 16%
• Boceprevir 16%
• Hepatitis C Virus Genotype 1 16%